Display Settings:

Format

Send to:

Choose Destination
    Drug Saf. 2009;32(4):275-82. doi: 10.2165/00002018-200932040-00002.

    How do we safely treat depression in children, adolescents and young adults?

    Source

    Department of Psychological Medicine, Children's, Youth and Women's Health Service, Women's and Children's Hospital, North Adelaide, South Australia, Australia. jon.jureidini@health.sa.gov.au

    Abstract

    Increasing concerns about the safety and efficacy of antidepressant drugs for children, adolescents and young adults have been countered by claims that reduced prescribing of antidepressants may have dangerous consequences. This leaves clinicians unsure as to how to weigh up the evidence and apply it to their patients. This paper promotes an approach of evaluating the evidence in each study according to the importance of the outcomes being measured in that study. It finds that on important measures such as mortality, hospitalization and quality of life, the evidence is unfavourable for antidepressants in this population. Here, an approach is suggested that primary care physicians might adopt with their depressed young patients. Through a combination of 'watchful waiting' and physical and emotional rehabilitation, physicians can actively intervene without reliance on medication or psychotherapy.

    PMID:
    19388719
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Adis, a Springer business

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk